A case of Ki-1-positive anaplastic large cell lymphoma of the pancreas is presented. The patient complained of abdominal pain and was jaundiced. Examination of a biopsy specimen obtained by duodenal endoscopy revealed malignant lymphoma, and surgery confirmed a large mass located in the region from the intra-pancreatic tissue around the lower common bile duct to the peri-pancreatic lymph nodes. Histologically, this tumor was composed mainly of large and giant neoplastic cells. Immunohistochemically, these cells were diffusely positive for Ki-1 and CD45RO antigens, indicating the features of Ki-1 anaplastic large cell lymphoma with a T-cell phenotype among non-Hodgkin's lymphoma. The histologic types of the majority of malignant lymphomas of the pancreas reported previously were considered to be diffuse-type non-Hodgkin lymphoma (probably with predominance of the B-cell phenotype), except for a single Japanese lymphoma case with a T-cell phenotype. This is therefore the first known case of Ki-1 anaplastic large cell lymphoma of the pancreas.
INTRODUCTION
Malignant lymphomas arising primarily in the pancreas, involving only the pancreatic parenchyma and/or peri-pancreatic lymph nodes, are rare, constituting less than 0.7% of all pancreatic malignancies (1) and 1% of non-Hodgkin's lymphomas (2) . Ki-1-positive anaplastic large cell lymphoma (Ki-1 ALCL) is an uncommon type of non-Hodgkin's malignant lymphoma first described by Stein et al. (3) in 1985. Since then, following the description in the updated Kiel classification (4) of 1988, the criteria for this tumor have been added to the recently published Revised European-American Classification of Lymphoid Neoplasms (REAL classification) (5) . Morphologically, this tumor is composed mainly of large blastic cells, often with horseshoeshaped or multiple nuclei and multiple or single prominent nucleoli. Moreover, the tumor cells grow in a cohesive pattern and often preferentially involve the lymph node sinuses, as well as extranodal sites such as soft tissue, bone and skin.
Here we report the first known case of Ki-1 ALCL of the pancreas and review the literature concerning pancreatic lymphomas.
CASE REPORT
A 46-year-old woman was admitted to the Medical Department of Hoshigaoka Koseinenkin Hospital in May 1994, complaining of right lumbar back pain and anorexia of one week's duration. Abdominal ultrasonography revealed a hypoechoic mass in the pancreatic head with a mildly dilated common bile duct (CBD). Physical examination demonstrated no superficial lymphadenopathy or anemia, but icteric conjunctivae, a flat and soft abdomen, and mild tenderness in the right upper quadrant. The RBC count was 479 × 10 4 /mm 3 and Hb level 12.0 g/dl. The WBC count was 5900/mm 3 with a normal lymphocyte percentage (23%). Aspiration of bone marrow cells revealed no abnormality (nucleocyte count: 30.7 10 4 /mm 3 ). The level of total protein was 6.7 g/dl. The total bilirubin level was 4.5 mg/dl (normal range 0.2-1.0 mg dl) with a direct bilirubin volume of 2.9 mg/dl. Other values included GOT 110 IU, GPT 182 IU, alkaline phosphatase 26.3 King-Armstrong units (KAU) (normal range 2-10 KAU), LAP 441 Goldbarg-Rutenberg units (GR), γ-GTP 145 IU/L and cholinesterase of 0.57 ∆pH. All these were abnormal, suggesting obstructive jaundice. Serum amylase was low at 100 IU (normal range 150-400) and urinary amylase was normal at 644 IU (normal range 100-1000). Although the serum levels of carbohydrate antigen 19-9, CEA, AFP and elastase 1 were all within normal limits at 6 U/ml, 1.7 ng/ml, 1 ng/ml and 270 U/ml respectively, serum carbohydrate antigen 125, normal value <35, was mildly elevated at 40 U/ml. Serum was negative for HTLV-1 antibody.
Abdominal ultrasonography and endoscopic ultrasonography revealed a swelling in the pancreatic head (approximately 41 39 mm) with invasion of the wall of the CBD, but a normal main pancreatic duct (MPD). Computed tomography (CT) of the abdomen showed a low-density mass, 4 cm in diameter, in the pancreatic head (Fig. 1) . Endoscopic retrograde pancreatography (ERP) showed no remarkable change in the MPD (Fig. 2) . Duodenal endoscopy revealed submucosal protrusion with erosion in the second portion of the duodenum, and a mucosal biopsy was performed. The biopsied specimen was diagnosed as malignant lymphoma. Abdominal angiography revealed mild dilatation of the anterior superior pancreaticoduodenal artery and encasement of the posterior superior pancreaticoduodenal artery.
With a diagnosis of a pancreatic malignancy, possibly lymphoma, pancreaticoduodenectomy and partial gastrectomy were performed at the Surgical Department of our hospital on June 20th, 1994. Postoperatively, the patient underwent combination chemotherapy (MACOP-P) consisting of one course of methotrexate (MTX), adriamycin (ADR), cyclophosphamide (CPM), vincristine (oncovin), prednisolone and peplomycin. The patient was alive and free of disease 1 year and 6 months after surgery.
PATHOLOGIC FINDINGS
Grossly, the resected tumor involving the posterior pancreatic head measured approximately 4 4 3 cm, was soft in consistency with good movability, and had invaded part of the duodenal wall. Table 1 .) Since serum antibody against HTLV-1 (a marker of adult T-cell leukemia) was negative in this patient, and Hodgkin's disease was excluded both histologically and immunohistochemically, this tumor was diagnosed as Ki-1 ALCL.
DISCUSSION
Non-Hodgkin's lymphoma frequently occurs at extranodal sites, most commonly in the gastrointestinal tract (7) and rarely in the pancreas (8) . It has, however, been reported that up to one third of patients with non-Hodgkin's lymphoma show pancreatic involvement at postmortem examination (9) . A primary pancreatic lymphoma is strictly localized to pancreatic tissue, with lymph node involvement only in the area of the pancreas; that is, corresponding to clinical stages I and II according to the Ann Arbor classification of malignant lymphoma (2). The present case was confirmed as a localized tumor in the pancreatic head region by surgical observation and examination of histological specimens. Although it was considered to be Ki-1 ALCL with a T-cell phenotype, this tumor might have been derived from activated lymphoid cells rather than from T cells, because further immunohistochemical results showed negative reactivity for CD3 antigen (T-cell marker). It has also been reported by Stein et al. (3) that CD30, a glycoprotein of 105/120 kDa, is expressed mainly on the cell surface and can be detected by the monoclonal antibody Ki-1, which was originally produced by immunization with a cell line derived from Reed-Sternberg cells of Hodgkin's disease. Moreover, it has been stressed by Miyake et al. (10) that CD30 antigen is expressed in various cell lineages such as ALCL, malignant histiocytosis, plasmacytoma, some non-Hodgkin's lymphomas other than ALCL, lymphomatoid papulosis and Hodgkin's disease, and that CD30 may be related in some instances to a cellular activation antigen. Of these nine, jaundice was evident in five cases and only two cases were judged to be clinical stage II. Six patients survived for a mean perod of 24 months after obtaining complete remission by chemotherapy. They concluded that the majority of patients with pancreatic lymphoma should be managed with chemotherapy and not surgery. Twelve patients with pancreatic lymphoma were reported by Mansour et al. (16) in 1989. They mentioned that both preoperative cytologic diagnosis and intraoperative frozen section diagnosis were unreliable, but that tumor markers, demonstrating a B-cell phenotype (10/12 cases) by immuno-histochemistry, yielded specific and accurate diagnoses of pancreatic lymphoma. Table 2 lists the 15 cases of primary pancreatic lymphoma reported previously in Japan. A case of malignant T-cell lymphoma of the pancreas was described by Satake et al. (20) . The patient showed diffuse enlargement of the entire pancreas with periaortic lymph node swelling, and histological examination of frozen sections obtained at laparotomy gave a diagnosis of non-Hodgkin's lymphoma (large cell type), immunohistochemically positive for CD3. The patient died 2 months after surgery. Among the 15 Japanese cases, the age of the patients ranged from 33 to 74 years (mean 52.2 yr), male:female ratio was 13:2 and the site of the pancreas involved was the head in nine cases, the tail in three, the body with head or tail in two and the whole pancreas in one. Histologic diagnosis revealed that the type with the highest incidence was non-Hodgkin's lymphoma (eight cases), diffuse, large and mixed cell types by the International Working Formulation, followed by single cases of diffuse lymphoma, small cleaved and small lymphocytic cell types, and one case of follicular lymphoma, small cleaved cell type. One case of Hodgkin's disease (mixed cell type) (18) was reported without immunohistochemical examination. Immunohistochemically, four cases were described as being of B-cell phenotype and only one case as T-cell phenotype. Survival in the Japanese patients exceeded 1 yr in only one. The present patient exhibited obstructive jaundice before surgery, but she is still alive over 1.5 yr after surgery and chemotherapy.
Ki-1 ALCL has often been misdiagnosed as anaplastic (ductal) carcinoma, Hodgkin's disease, malignant histiocytosis, sarcoma or amelanotic melanoma (5) . Recently, however, immunohistochemical staining for lymphoid markers has allowed definite distinction between these diseases.
Chott et al. (23) described 10 cases of extranodal ALCL among 41 cases of Ki-1 ALCL, but none had primary pancreatic involvement. They mentioned that there were two cytomorphological groups: group A demonstrating pleomorphic large cells, and group B with a monomorphic appearance, very large or relatively small cells, but a T cell phenotype in the majority of cases. They pointed out that the immunohistochemical expression of Ki-1 antigen should be seen in at least 80% of the tumor cells on paraffin sections when ALCL was diagnosed. In their report, the mean age of the 41 patients was 50 yr, with a male:female ratio of 23:18 and an overall median survival of 13 mo. Although both age <40 yr and limited stage of disease (clinical stages I and II) were significantly associated with long survival, lymphoma morphology classified as group A (pleomorphic large cell type) survived longer than group B (rather monomorphic cell type), though the difference was not significant. Our case of a 46-yr-old female patient was histologically considered to be the pleomorphic large cell type [type A in their report (23) ] and thus longer survival could be expected (currently 18 months).
In Japan, Nasu et al. (24) have reported five cases of primary ALCL involving the gastrointestinal tract but no pancreatic lymphomas among 69 cases of Ki-1 ALCL. Mann et al. (25) reported two cases of Ki-1 ALCL with abundant neutrophils that were localized to retroperitoneal lymph nodes.
Ki-1 ALCL is included in the updated Kiel classification (4) and is usually classified as a high-grade lymphoma, although it sometimes shows slow growth. According to the recently published REAL classification (5), there are two clinical types in Ki-1 ALCL. One is a primary nodal/extranodal and systemic form in both adults and children, which expresses EMA + and cutaneous lymphocyte antigen (CLA) -and shows moderately aggressive behavior. The other is a primary cutaneous form occurring in adults only, which expresses EMA -and CLA + and has the possibility of spontaneous regression. Our present case was a primary nodal/extranodal form of Ki-1 ALCL without skin lesions, but with immunohistochemical negativity for EMA. 
